{
  "nctId": "NCT02276885",
  "briefTitle": "Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial",
  "officialTitle": "Prone Partial Breast Irradiation (PBI): A Prospective Randomized Trial Comparing Five Versus Three Fractions",
  "protocolDocument": {
    "nctId": "NCT02276885",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2018-10-12",
    "uploadDate": "2024-12-06T11:37",
    "size": 1068739,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02276885/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 284,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2014-10-28",
    "completionDate": "2026-12-07",
    "primaryCompletionDate": "2023-12-07",
    "firstSubmitDate": "2014-10-24",
    "firstPostDate": "2014-10-28"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Post-menopausal women defined as either:\n\n  1. at least 2 years without menstrual period\n  2. patients older than 50 with serological evidence of post-menopausal status\n  3. hysterectomized patients of any age with FSH confirmation of post- menopausal status\n* pT1 breast cancer, excised with negative margins. Criteria for low risk-pTis:\n\n  1. Screen-detected\n  2. Low to intermediate nuclear grade\n  3. \\< 2.5cm in size\n  4. Resected with negative margins at \\>3mm)\n* clinically N0 or pN0 or sentinel node negative breast cancer\n\nExclusion Criteria:\n\n* previous radiation therapy to the ipsilateral breast\n* presence of a proportion of DCIS in the core biopsy specimen which is compatible with extensive intraductal component (EIC)",
    "healthyVolunteers": false,
    "sex": "FEMALE",
    "minimumAge": "50 Years",
    "maximumAge": "90 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Percentage of Participants With Grade 2 or 3 Fibrosis",
        "timeFrame": "60 months"
      }
    ],
    "secondary": [
      {
        "measure": "Rate of Isolated Local/Regional Recurrences",
        "timeFrame": "1 year post randomization"
      },
      {
        "measure": "Rate of Concomitant Local/Regional and Distant Recurrences",
        "timeFrame": "1 year post randomization"
      },
      {
        "measure": "Rate of Isolated Local/Regional Recurrences",
        "timeFrame": "2 years post randomization"
      },
      {
        "measure": "Rate of Concomitant Local/Regional and Distant Recurrences",
        "timeFrame": "2 years post randomization"
      },
      {
        "measure": "Rate of Isolated Local/Regional Recurrences",
        "timeFrame": "3 years post randomization"
      },
      {
        "measure": "Rate of Concomitant Local/Regional and Distant Recurrences",
        "timeFrame": "3 years post randomization"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 6,
      "otherCount": 0,
      "totalCount": 7
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": false,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 54,
    "complexityCategory": "Complex"
  },
  "collectionDate": "2025-09-22T02:30:56.776Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}